The University of Arizona
Institutional Knowledge Map (KMap)
Picture of Scott Sherman

Scott Sherman

Associate Professor, Neuroscience - GIDP | Associate Professor, Neurosurgery | Associate Professor, Physiological Sciences - GIDP | Clinical Instructor | Associate Professor, Physiology | Professor, Neurology | Member of the Graduate Faculty

Neurology
Map Page
50+ Collaborators
$8.6M / $12.8M Funding
30+ Grants
70+ Publications
10+ News

Research Area

parkinson's disease, clinical trial, ketamine, treatment, neurology, neuroscience, l-dopa-induced dyskinesia, movement disorders, mechanisms, pharmacology, dyskinesia, clinical trials, preclinical model, dopamine transporter, l-dopa, low-dose, neurological disorders, medical research, botulinum toxin, efficacy

    Page 1 of 8

    Chart
    Bar chart with 30 bars.
    The chart has 1 X axis displaying Year.
    The chart has 1 Y axis displaying values. Data ranges from 1 to 9.
    End of interactive chart.
    Recent

    Differential effects of opioid receptor antagonism on the anti-dyskinetic and anti-parkinsonian effects of sub-anesthetic ketamine treatment in a preclinical model

    2024

    Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion

    2023
    opioid receptors, dyskinesia, l-dopa, dopamine depletion, preclinical model

    WEARABLE SENSOR-BASED CHRONIC CONDITION SEVERITY ASSESSMENT: AN ADVERSARIAL ATTENTION-BASED DEEP MULTISOURCE MULTITASK LEARNING APPROACH

    2022

    Pilot Study for Correlation of Heart Rate Variability and Dopamine Transporter Brain Imaging in Patients with Parkinsonian Syndrome

    2022
    parkinsonian syndrome, heart rate variability, dopamine transporter, brain imaging

    Practical application of DaTQUANT with optimal threshold for diagnostic accuracy of dopamine transporter SPECT

    2021
    neuroimaging, diagnostic accuracy, dopamine transporter, data analysis, clinical applications

    Fall Detection with Wearable Sensors: A Hierarchical Attention-based Convolutional Neural Network Approach

    2021
    machine learning, healthcare, wearable technology, signal processing, fall prevention

    Evaluation of microglia in a rodent model of Parkinson s disease primed with L-DOPA after sub-anesthetic ketamine treatment.

    2021
    neuroinflammation, parkinson's disease, ketamine, microglia, l-dopa

    Highly-selective mu;opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model

    2020

    Spectral Signatures of L-DOPA-Induced Dyskinesia Depend on L-DOPA Dose and are Suppressed by Ketamine.

    2020
    neuroscience, pharmacology, drug effects, dyskinesia, spectroscopy

    Accuracy of Dopamine Transporter Imaging with I-Ioflupane in Hispanic and Non-Hispanic Patients

    2020
    dopamine transporter imaging, ethnicity, diagnostic imaging, parkinson's disease, neuroimaging

    • Marlys Witte

    • Helena Morrison

    • Russell Witte

    • Todd Vanderah

    • Julia Fisher

    Page 1 of 12

    Page 1 of 3

    Scott Sherman | KMap Profile - Institutional Knowledge Map (KMap)